NCT04485871View on ClinicalTrials.gov

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 19, 2019

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Type 2 DiabetesInflammationInsulin Sensitivity/ResistanceFatty Acids, Omega-3
Interventions
DIETARY_SUPPLEMENT

Omega-3 fatty acids

Triple Strength Omega-3 from Webber Naturals; 4 oral softgels (600 mg EPA and 300 mg DHA / softgel)

Trial Locations (1)

H2W 1R7

RECRUITING

Montreal Clinical Research Institute, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Institut de Recherches Cliniques de Montreal

OTHER